IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma
Human Pathology Jul 24, 2018
Hui S, et al. - Researchers assessed the prognostic significance of IMP3 and Fli-1 in malignant peritoneal mesothelioma (MPeM). For this investigation, diagnostic biopsies of 44 MPeM subjects were centrally gathered and were immunohistochemically examined for expression of IMP3, Fli-1, and Ki-67. They found that tumor-directed treatment, a lower PCI, Stage I, lower Ki-67LI and lower level IMP3 expression had a statistically significant positive effect on overall survival. The main finding of this study was that IMP3, along with tumor-directed treatment protocols, was a powerful prognosticator in patients with MPeM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries